SELLAS Life Sciences
SLS
SLS
28 hedge funds and large institutions have $2.68M invested in SELLAS Life Sciences in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less capital invested
Capital invested by funds: $4.57M → $2.68M (-$1.89M)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
28
Holding in Top 10
–
Calls
$700K
Puts
$31K
Top Buyers
| 1 | +$242K | |
| 2 | +$25.1K | |
| 3 | +$15.2K | |
| 4 |
CGA
Crescent Grove Advisors
Lake Forest,
Illinois
|
+$8.58K |
| 5 |
VF
Virtu Financial
New York
|
+$8.58K |
Top Sellers
| 1 | -$93K | |
| 2 | -$75.2K | |
| 3 | -$70K | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$33K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$28.4K |